MIR6729

Across TCGA pan-cancer cohorts, MIR6729 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR6729 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher MIR6729 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6729 expression acts as an unfavorable survival marker.

LUSC, COAD, and ACC are the cancer types where MIR6729 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	All	0.505	0.791	<.001	84	view →
COAD	DFS	Tertile	II,III,IV	0.224	0.654	.007	78	view →
ACC	OS	Tertile	All	0.147	0.685	.018	18	view →
LIHC	DFS	Tertile	All	0.094	0.526	.017	18	view →
LUAD	OS	Tertile	II,III,IV	0.127	0.682	<.001	18	view →
PRAD	OS	Tertile	All	0.892	0.996	<.001	18	view →
THCA	OS	Tertile	All	0.342	0.955	.003	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MIR6729–LUSC (DFS)

Open the LUSC breakdown →